跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROPOFOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PROPOFOL
Authorized
STANDARD
PROPOFOL
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
208a3a36c146cb3a
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
208a3a36c146cb3a
Drug Approval Canada Name
PROPOFOL
Product Name
PROPOFOL
Status
Cancelled Post Market
Status Date
2024-01-30
Original Market Date
2018-04-24
Din
02468336
Drug Class
Human
Dosage Form
Emulsion
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
28:04.08
Atc Original
N01AX10 PROPOFOL
Atc Name
n 01 ax 10
Aig Number
0121833001
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
PROPOFOL
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
208a3a36c146cb3a
Type
Standard
Back to Health Canada Approvals